echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: Auxilin is a novel congenital heart block susceptibility gene that directly affects fetal heart function

    ARD: Auxilin is a novel congenital heart block susceptibility gene that directly affects fetal heart function

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: Neonatal lupus erythematosus (NLE) may develop following transplacental transfer of maternal autoantibodies and is associated with cardiac manifestations (congenital heart block, CHB) including atrioventricular block, atrial and ventricular arrhythmias, and myocardial sic.


    Methods: Genome-wide association studies were performed in families with at least one CHB cas.


    Results: We identified DNAJC6 as a novel fetal susceptibility gene, and reduced cardiac expression of DNAJC6 was associated with disease risk genotype.


    Conclusions: This study identifies adjuvant as the first genetic susceptibility factor for NLE to modulate cardiac function, opening new avenues for developing screening and treatment strategies for congenital heart bloc.


    Source: Meisgen S, Hedlund M, Ambrosi A, et a.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.